英文名称 | 中文名称 | CAS |
---|---|---|
Abiraterone | 17-(3-吡啶基)-雄甾-5,16-二烯-3β–醇;阿比特龙杂质B | 154229-19-3 |
Olaparib | 奥拉帕利 | 763113-22-0 |
Nintedanib Ethanesulfonate Salt | 乙磺酸尼达尼布 | 656247-18-6 |
(S)-diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate | (S)-2-(4-(3-氯-4-氟苯基氨基)-7-(四氢呋喃-3-基氧基)喹唑啉-6-基氨基)-2-氧代乙基膦酸二乙酯 | 618061-76-0 |
Alectinib hydrochloride | 阿来替尼 | 1256589-74-8 |
卡培他滨杂质A | 66335-38-4 | |
4-QuinazolinaMine | 4-[(3-氯-4-氟苯基)氨基]-6-硝基-7-((S)-四氢呋喃-3-基氧基)-喹唑啉 | 314771-88-5 |
恩扎卢胺杂质;1,3-双-(4-氰基-3-三氟甲基-苯基)-硫脲 | 1415564-70-3 | |
Palbociclib impurity E | 6-溴-8-环戊基-5-甲基-2-[[5-(哌嗪-1-基)吡啶-2-基]氨基]-8H-吡啶并[2,3-D]嘧啶-7-酮 | 851067-56-6 |
恩扎卢胺杂质 | 1289942-55-7 | |
3-Amino-4-methylbenzoic acid | 3-氨基-4-甲基苯甲酸;尼洛替尼杂质H | 2458-12-0 |
尼洛替尼单盐二水 | 923289-71-8 | |
仑伐替尼甲磺酸盐DMSO溶剂化物 | 917572-43-1 | |
瑞博西尼杂质A | 1139453-98-7 | |
Carfilzomib | 卡非佐米 | 868540-17-4 |
Lapatinib impurity A;2-chloro-4-((6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-yl)amino)phenol | 拉帕替尼杂质 | 1268997-70-1 |
Ribociclib | 瑞博西尼 | 1374639-79-8 |
Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate | 德拉沙星 | 442526-91-2 |
卡培他滨 | 154361-50-9 | |
尼达尼布杂质B | 2093243-16-2 | |
Lapatinib impurity E;N-(3-chloro-4-((4-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfonate) | 1026818-86-9 | |
Lapatinib impurity H;Lapatinib Impurity 4 | N-(3-氯-4-((3-氟苄基)氧基)苯基)-6-(5-((5-(4-((3-氯-4-((3-氟苄基)氧基)苯基)氨基)喹唑啉-6-基)呋喃-2-基)甲基)(2-(甲磺酰基)乙基)氨基)甲基)呋喃-2-基)喹唑啉-4-胺 | 2172855-57-9 |
Regorafenib Impurity | 4-[4-[3-[4-氯-3-(三氟甲基)苯基]脲基]-3-[4-[3-[4-氯-3-(三氟甲基)苯基]脲基]-3-氟苯氧基]苯氧基]-N-甲基吡啶酰胺;瑞戈非尼杂质I | 2098799-13-2 |
Oseltamivir phosphate | 磷酸奥司他韦 | 204255-11-8 |
Lapatinib impurity B;N-De[2-(Methylsulfonyl)ethyl] Lapatinib | 697299-82-4 | |
Afatinib diMaleate | 双马来酸盐阿法替尼 | 850140-73-7 |
尼达尼布杂质A | 894783-71-2 | |
Lapatinib impurity I;Lapatinib impurity P | 拉帕替尼杂质P | 633370-23-7 |
Neratinib | 来那替尼 | 698387-09-6 |
Lapatinib ditosylate | 二甲苯磺酸拉帕替尼 | 388082-78-8 |
Regorafenib | 瑞戈非尼 | 755037-03-7 |
尼达尼布杂质G | 262368-30-9 | |
Lapatinib impurity F;Lapatinib IMpurity 8 | 5-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉基]-2-呋喃甲醇 | 320337-48-2 |
Afatinib impurity;Ethyl hydrogen (2-((4-((3-chloro-4-fluorophenyl)amino) -7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate | (2-((4-((3-氯-4-氟苯基)氨基)-7-(((S)四氢呋喃-3-基)氧基-6-喹唑啉基)氨基)-2-乙氧基)膦酸单乙酯 | |
(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate | 阿比特龙杂质J | |
Rucaparib | 瑞卡帕布 | 1327258-57-0 |
relugolix impurity | 6-(6-氨基苯基)-1-(2,6-二氟苄基)-5-(二甲氨基)甲基-3-(6-甲氧基哒嗪-3-基)噻吩[2,3-d]嘧啶-2,4(1H,3H)-二酮 | 1589503-93-4 |
Abiraterone Impurity | 17-(3-吡啶基)雄甾-5,16-二烯-3β-(2-四氢吡喃基)-醇;阿比特龙杂质D | 1431753-70-6 |
AKOS BB-3093 | 3-氨基-4-甲基苯甲酸乙酯;尼洛替尼杂质G | 41191-92-8 |
卡培他滨杂质F | 921769-65-5 | |
Cabazitaxel | 卡巴他赛 | 183133-96-2 |
Crisaborole | 克立硼罗 | 906673-24-3 |
5-(piperazin-1-yl)pyridin-2-aMine | 5-(哌嗪-1-基)吡啶-2-胺;哌柏西利杂质A | 1082876-26-3 |
lenvatinib Mesylate | 甲磺酸仑伐替尼 | 857890-39-2 |
relugolix | 瑞卢戈利 | 737789-87-6 |
Enzalutamide | 恩扎卢胺 | 1242137-16-1 |
恩扎卢胺杂质I | 1242137-15-0 | |
Palbociclib impurity D | 4-[6-[(6-乙酰基-8-环戊基-7,8-二氢-5-甲基-7-氧代吡啶并[2,3-D]嘧啶-2-基)氨基]-3-吡啶基]-1-哌嗪羧酸叔丁酯 | 1651214-74-2 |
Abiraterone Impurity | 17-(4-吡啶基)-雄甾-5,16-二烯-3β–乙酸酯;阿比特龙杂质F | 165334-69-0 |
卡培他滨杂质B | 3094-09-5 | |
Dasatinib | 达沙替尼 | 302962-49-8 |
4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE | 4-(4-氨基-3-氟苯氧基)-N-甲基吡啶酰胺;瑞戈非尼杂质B | 757251-39-1 |
卡培他滨杂质E | 910129-15-6 | |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]- | 8-环戊基-5-甲基-2-[[(5-哌嗪-1-基吡啶-2-基)]氨基]-8H-吡啶并[2,3-D]嘧啶-7-酮;哌柏西利杂质B | 571190-22-2 |
Palbociclib impurity G | 8-环戊基-5-甲基-2-(((5-(哌嗪-1-基)吡啶-2-基)氨基)-6-乙烯基吡啶并[2,3-d]嘧啶-7(8H)-酮 | 2204863-06-7 |
Afatinib impurity;Afatinib Impurity des-EJA | (S,E)-N-(4-(3-氯-4-氟苯基胺基)-7-((四氢呋喃-3-基)氧基)-6-喹唑啉)-2-丁烯酰胺 | 2223677-64-1 |
恩扎卢胺杂质J | 1895865-11-8 | |
Afatinib impurity; | (E)-N-(4-((3-氯-4-氟苯基)胺)-7-乙氧基喹唑啉-6-基)-4-(二甲氨基)丁-2-烯酰胺 | 2085843-51-0 |
Irinotecan hydrochloride trihydrate | 盐酸伊立替康 | 136572-09-3 |
Lapatinib impurity J;3-Chloro-4-(3-fluorobenzyloxy)aniline | 3-氯-4-(3-氟苄氧基)苯胺 | 202197-26-0 |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid | 4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸;尼洛替尼杂质A | 641569-94-0 |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester | 4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸;尼洛替尼杂质E | 917392-54-2 |
Afatinib | 阿法替尼 | 850140-72-6 |
维奈妥拉 | 1257044-40-8 | |
Afatinib impurity;(R,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide | (R,E)-N-{4-[(3-氯-4-氟苯基)氨基]-7-[(四氢呋喃-3-基)氧基]喹唑啉-6-基}-4-(二甲基氨基)丁-2-烯酰胺 | 945553-91-3 |
尼达尼布杂质C | 2097505-01-4 | |
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate | 阿比特龙杂质k | 1239-13-6 |
4-[2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yl]oxyanilino]-N-methylpyridine-2-carboxamide | 4-[3-氟-4-[[2-(甲基氨基甲酰基)吡啶-4-基]氨基]苯氧基]-N-甲基吡啶酰胺;瑞戈非尼杂质D | 1855006-12-0 |
Lapatinib impurity D;N-De[2-(Methylsulfonyl)ethyl] Lapatinib | N-(3-氯-4-((2-氟苄氧基)苯基)-6-(5-(((2-(甲磺酰基)乙基)胺)甲基)呋喃-2-基)喹唑啉-4-胺 | 1393112-45-2 |
Lapatinib impurity G;5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde | 5-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉]-2-呋喃甲醛 | 231278-84-5 |
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine | N4-(3-氯-4-氟苯基)-7-[[(3S)-四氢-3-呋喃基]氧基]-4,6-喹唑啉二胺 | 314771-76-1 |
Tedizolid Phosphate | 磷酸特地唑胺 | 856867-55-5 |
4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide | 4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(3-(5-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯基)苯甲酰胺;尼洛替尼杂质C | 641571-15-5 |
NILOTINIB IMPURITY | 4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-乙基基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰胺;尼洛替尼杂质F | 2119583-24-1 |
4-Amino-3-fluorophenol | 4-氨基-3氟苯酚;瑞戈非尼杂质A | 399-95-1 |
Palbociclib impurity C | 6-乙酰基-8-环己基-5-甲基-2-[[5-(哌嗪-1-基)吡啶-2-基]氨基]-8H-吡啶并[2,3-D]嘧啶-7-酮;哌柏西利杂质C | |
卡培他滨杂质C | 161599-46-8 | |
Abiraterone acetate | 醋酸阿比特龙 | 154229-18-2 |
brivaracetam | 布瓦西坦 | 357336-20-0 |
卡培他滨杂质D | 162204-30-0 | |
培美曲塞七水物 | 357166-29-1 | |
罗沙司他 | 808118-40-3 | |
FLUCOFURON | 1-[4-氯-3-(三氟甲基)苯基]-3-[4-氯-3-(三氟甲基)苯基]脲;瑞戈非尼杂质F | 370-50-3 |
Lenvatinib Impurity | 仑伐替尼杂质N | 2143930-77-0 |
Bortezomib | 硼替佐米 | 179324-69-7 |
1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-hydroxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea | 瑞卢戈利杂质 | 1801551-07-4 |
Benzamide, 3-[[5-chloro-4-(3-pyridinyl)-2-pyrimidinyl]amino]-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]- | 4-甲基-3-((5-氯-4-(3-吡啶基)-2-嘧啶基)氨基)-N-(3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯基)苯甲酰胺;尼洛替尼杂质D | 2469039-94-7 |
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯胺;尼洛替尼杂质B | 641571-11-1 |
索拉非尼FORMI | 475207-59-1 | |
阿帕鲁胺 | 956104-40-8 | |
Elagolix Sodium | 依拉格力 | 832720-36-2 |
恩扎卢胺杂质P | 1289942-66-0 | |
瑞博西尼杂质E | 1374639-78-7 | |
恩扎卢胺杂质;4-氨基-2-三氟甲基-苄腈 | 654-70-6 | |
恩扎卢胺杂质 | 1242137-18-3 | |
恩扎卢胺杂质 | 1895865-10-7 | |
4-Dimethylaminopyridine | 4-二甲氨基吡啶;阿比特龙杂质I | 1122-58-3 |
联系方式